Evans Vanodine

Evans Vanodine has been developing and manufacturing cleaning and hygiene products for over 100 years. Our products cover an extensive range of applications within industrial and professional hygiene sectors, from infection control and hand hygiene, to catering and hospitality. The company, still owned and run by the Evans family, currently exports products to over 85 countries worldwide.

Approach to Healthcare:

Our approach to healthcare is centred on supporting safe, clean and infection-controlled environments through high-quality cleaning, hygiene and disinfection solutions. We invest in research, development and rigorous product testing to ensure our products are effective, compliant and fit for purpose. Our UKAS-accredited microbiology laboratory validates and ensures all of our products comply with regulations and that virucidal and bactericidal claims are substantiated by BS EN test methods. By combining innovation, proven efficacy and quality assurance, we help healthcare settings maintain high standards of cleanliness, patient safety and infection prevention. We have been recognised with two Queen’s Awards for Enterprise, and Planet Mark and EcoVadis accreditations

Impact on Healthcare:

Our products and services contribute to improved healthcare outcomes by helping reduce the risk of healthcare-associated infections and supporting effective infection prevention and control practices. Through scientifically tested cleaning and disinfectant solutions, healthcare providers can maintain cleaner, safer environments for patients, staff and visitors. Our products are supported by accredited microbiological testing, ensuring performance claims are evidence-based and reliable. By assisting organisations to meet healthcare cleanliness standards and regulatory requirements, we help enhance patient safety, strengthen quality assurance programmes and promote confidence in healthcare environments. Ultimately, our solutions support safer care delivery and continuous improvement in healthcare hygiene standards.

Innovation:

The most recent innovation we are launching into the healthcare sector is Vanocide, a ready-to-use chlorine dioxide sporicidal disinfectant designed to support effective infection prevention while simplifying cleaning procedures. Vanocide provides broad-spectrum efficacy , including activity against spores with a 5 minute contact time to help reduce medical device downtime. Its ready-to-use formulation requires no activation, preparation or rinsing, helping to minimise the risk of user error and streamline workflows. It also offers broad material compatibility across commonly used healthcare surfaces and medical devices.

Future Direction:

Evans Vanodine’s future direction in healthcare is to strengthen our support for infection prevention through effective cleaning, disinfection, and hand hygiene products, backed by technical expertise and dependable supply.
Our research and development capabilities will support product improvements informed by customer needs, recognised efficacy testing and practical requirements. Clear guidance on application, dilution, and contact times, alongside training and COSHH resources, will help healthcare teams use products safely and consistently.
We will continue to explore opportunities to reduce cost in use and environmental impact through concentrated formulations, controlled dosing, and packaging improvements, while maintaining hygiene performance.
Approved suppliers, multiple sourcing wherever possible, stock planning and early communication of disruption will support supply continuity. This approach will help us remain a responsive healthcare hygiene partner as customer requirements evolve.